{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:06Z","timestamp":1793946486864,"version":"4.8.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105446","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:38:43Z","timestamp":1782923923000},"page":"105446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance"],"prefix":"10.1016","volume":"226","author":[{"given":"Franciska","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Bagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lastraioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105446_bib1","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/2326-6066.CIR-23-0045","article-title":"Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple-negative breast cancer","volume":"11","author":"Adewunmi","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib2","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180704","article-title":"Long noncoding RNA MIAT regulates apoptosis and the apoptotic response to chemotherapeutic agents in breast cancer cell lines","volume":"38","author":"Almnaseer","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-11-5","article-title":"miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer","volume":"11","author":"Augoff","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103784","article-title":"Epigenetics in autoimmune diseases: unraveling the hidden regulators of immune dysregulation","volume":"24","author":"Bagni","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.critrevonc.2026.105446_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2021.107435","article-title":"Circulating miRNome profiling data in Beh\u00e7et\u2019s syndrome","volume":"38","author":"Bagni","year":"2021","journal-title":"Data Brief."},{"key":"10.1016\/j.critrevonc.2026.105446_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104076","article-title":"Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis","volume":"127","author":"Banerjee","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1186\/s12885-019-6179-y","article-title":"BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis","volume":"19","author":"Barton","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/1878-0261.12446","article-title":"Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death","volume":"13","author":"Beltr\u00e1n-Anaya","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib9","article-title":"Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 silencing to block wnt\/ \u03b2-catenin signaling pathway for synergistic reversal of radioresistance and effective cancer radiotherapy","volume":"7","author":"Bi","year":"2020","journal-title":"Adv. Sci. (Weinh. )."},{"key":"10.1016\/j.critrevonc.2026.105446_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/mmr.2025.13528","article-title":"Landscape of lncRNAs expressed in Mexican patients with triple-negative breast cancer","volume":"31","author":"Castro-Oropeza","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.32604\/or.2023.028256","article-title":"The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway","volume":"31","author":"Cen","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202000007","article-title":"Bioinformatic identification of a breast-specific transcript profile","volume":"14","author":"Chen","year":"2020","journal-title":"Proteom. Clin. Appl."},{"key":"10.1016\/j.critrevonc.2026.105446_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12935-020-01580-6","article-title":"Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p\/OTX1 axis","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105446_bib15","first-page":"339","article-title":"Stat3\/Oct-4\/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066","volume":"53","author":"Cheng","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41598-024-51947-2","article-title":"LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer","volume":"14","author":"Cisneros-Villanueva","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.7150\/jca.29670","article-title":"LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer","volume":"10","author":"Collina","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib18","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/cancers13112644","article-title":"LncRNA PART1 promotes proliferation and migration, is associated with cancer stem cells, and alters the miRNA landscape in triple-negative breast cancer","volume":"13","author":"Cruickshank","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000493956","article-title":"Mining prognostic significance of MEG3 in human breast cancer using bioinformatics analysis","volume":"50","author":"Cui","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib20","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1002\/cam4.6600","article-title":"Roles of long noncoding RNA in triple-negative breast cancer","volume":"12","author":"Das","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib21","article-title":"silico analyses identify lncRNAs WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors","volume":"15","author":"de Bastos","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.critrevonc.2026.105446_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105249","article-title":"The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome","volume":"161","author":"De Palma","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.21037\/atm-22-2900","article-title":"The synergistic effect of CDKN2B-AS1 and SPC25 on triple-negative breast cancer","volume":"10","author":"Deng","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib24","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105446_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-020-02926-8","article-title":"M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2","volume":"11","author":"Dong","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105446_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-024-02058-4","article-title":"The lncRNAMALAT1-WTAP axis: A novel layer of EMT regulation in hypoxic triple-negative breast cancer","volume":"10","author":"Dragonetti","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.critrevonc.2026.105446_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8096764","article-title":"Prognostic Implications of MALAT1 and BACH1 expression and their correlation with CTCs and Mo-MDSCs in triple negative breast cancer and surgical management options","author":"Elbasateeny","year":"2022","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib29","article-title":"A unique circulating miRNA profile highlights thrombo-inflammation in Beh\u00e7et\u2019s syndrome","volume":"2021","author":"Emmi","year":"2021","journal-title":"Ann. Rheum. Dis. annrheumdis"},{"key":"10.1016\/j.critrevonc.2026.105446_bib30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/jcb.29409","article-title":"Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels","volume":"121","author":"Evans","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib31","article-title":"Long Intergenic Non-Coding RNAs and BRCA1 in breast cancer pathogenesis: neighboring companions or nemeses?","volume":"11","author":"Fadebi","year":"2025","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.critrevonc.2026.105446_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1186\/s12885-024-13019-6","article-title":"The lncRNA AFAP1-AS1 is upregulated in metastatic triple-negative breast tumors and controls hypoxia-activated vasculogenic mimicry and angiogenesis","volume":"24","author":"Garcia-Hern\u00e1ndez","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib33","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41388-018-0586-4","article-title":"The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers","volume":"38","author":"Gooding","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105446_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12967-023-03967-1","article-title":"LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets","volume":"21","author":"Guo","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fonc.2019.01325","article-title":"Novel breast-specific long non-coding RNA LINC00993 acts as a tumor suppressor in triple-negative breast cancer","volume":"9","author":"Guo","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature07672","article-title":"Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals","volume":"458","author":"Guttman","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105446_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2018.09.018","article-title":"Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway","volume":"359","author":"Han","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12951-023-02168-8","article-title":"Coordinated modulation of long non-coding RNA ASBEL and curcumin co-delivery through multicomponent nanocomplexes for synchronous triple-negative breast cancer theranostics","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105446_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108428","article-title":"Androgen receptor-induced IncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p-CCR5 axis","volume":"301","author":"Hu","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2235768","article-title":"A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis","volume":"24","author":"Hu","year":"2023","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-020-01561-7","article-title":"Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer","volume":"39","author":"Hua","year":"2020","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib42","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.18632\/aging.202254","article-title":"Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcac042","article-title":"Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment","volume":"4","author":"Jackson","year":"2022","journal-title":"NAR Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib44","doi-asserted-by":"crossref","first-page":"40418","DOI":"10.18632\/oncotarget.9622","article-title":"Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer","volume":"7","author":"Jadaliha","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105446_bib45","unstructured":"Jiang, D., Wang, C., He, J., 2020. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt\/B-catenin signaling pathway. undefined."},{"key":"10.1016\/j.critrevonc.2026.105446_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2021.08.005","article-title":"lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment","volume":"25","author":"Jin","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105446_bib47","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1172\/JCI81568","article-title":"RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105446_bib48","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s11010-024-04933-1","article-title":"Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy","volume":"479","author":"Kadian","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib49","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.0904715106","article-title":"Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression","volume":"106","author":"Khalil","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105446_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1771","article-title":"Gene expression profiling and histopathological characterization of triple-negative\/basal-like breast carcinomas","volume":"9","author":"Kreike","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib51","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.21873\/anticanres.11224","article-title":"Long noncoding RNA snaR regulates proliferation, migration and invasion of triple-negative breast cancer cells","volume":"36","author":"Lee","year":"2016","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105446_bib53","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105446_bib54","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/cancers13051046","article-title":"Targeting PVT1 Exon 9 Re-expresses claudin 4 protein and inhibits migration by claudin-low triple negative breast cancer cells","volume":"13","author":"Levine","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib55","doi-asserted-by":"crossref","first-page":"13401","DOI":"10.3390\/ijms241713401","article-title":"SP1-induced upregulation of LncRNA AFAP1-AS1 promotes tumor progression in triple-negative breast cancer by regulating mTOR pathway","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib56","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.4081\/ejh.2022.3529","article-title":"Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p\/Bcl-2 axis","volume":"66","author":"Li","year":"2022","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib57","article-title":"Sonographic features of triple-negative breast carcinomas are correlated with mRNA-IncRNA signatures and risk of tumor recurrence","volume":"10","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s13577-019-00273-1","article-title":"LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458\/SOCS1 axis in triple-negative breast cancer","volume":"32","author":"Li","year":"2019","journal-title":"Hum. Cell."},{"key":"10.1016\/j.critrevonc.2026.105446_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biopha.2018.05.056","article-title":"Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p","volume":"104","author":"Li","year":"2018","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105446_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12935-020-01261-4","article-title":"LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53\/TNFAIP8 pathway","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105446_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104571","article-title":"Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment","volume":"91","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105446_bib62","article-title":"A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth","volume":"10","author":"Liang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb3295","article-title":"The LINK-A IncRNA activates normoxic HIF1a signaling in triple-negative breast cancer","volume":"18","author":"Lin","year":"2016","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib64","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.7150\/ijms.45706","article-title":"NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1","volume":"17","author":"Lin","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib65","doi-asserted-by":"crossref","first-page":"20584","DOI":"10.18632\/oncotarget.7828","article-title":"Long non-coding RNAs as prognostic markers in human breast cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105446_bib66","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3892\/mmr.2014.3089","article-title":"Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer","volume":"11","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib67","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.gendis.2022.07.006","article-title":"JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1","volume":"10","author":"Liu","year":"2022","journal-title":"Genes. Dis."},{"key":"10.1016\/j.critrevonc.2026.105446_bib68","article-title":"A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2026.105446_bib69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/dna.2019.5223","article-title":"A novel prognostic signature of mRNA-IncRNA in breast cancer","volume":"39","author":"Liu","year":"2020","journal-title":"DNA Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"Stem Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215781","article-title":"Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis","volume":"543","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105446_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126147","article-title":"CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy","volume":"250","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib73","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.62347\/VIXN9362","article-title":"Construction and validation of immune-associated lncRNA model for predicting immune status and therapeutic reactions of triple-negative breast cancer","volume":"16","author":"Liu","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib74","first-page":"19","article-title":"HOX Transcript Antisense RNA HOTAIR abrogates vasculogenic mimicry by targeting the angiomir-204\/FAK axis in triple negative breast cancer cells","volume":"6","author":"Lozano-Romero","year":"2020","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.critrevonc.2026.105446_bib75","first-page":"673","article-title":"Ursolic acid enhances cytotoxicity of doxorubicin-resistant triple-negative breast cancer cells via ZEB1-AS1 \/miR-186-5p\/ ABCC1 Axis","volume":"37","author":"Lu","year":"2022","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.critrevonc.2026.105446_bib76","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1002\/jcb.29572","article-title":"ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA","volume":"121","author":"Luo","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820980763","article-title":"Long non-coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2","volume":"19","author":"Luo","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105446_bib78","doi-asserted-by":"crossref","first-page":"13047","DOI":"10.18632\/oncotarget.7509","article-title":"LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer","volume":"7","author":"Lv","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105446_bib79","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2018.04.119","article-title":"LincRNA-RoR\/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1","volume":"500","author":"Ma","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105446_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120810","article-title":"Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis","volume":"306","author":"Ma","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-83665-0","article-title":"A novel lncRNA AC112721.1 promotes the progression of triple-negative breast cancer by directly binding to THBS1 and regulating miR-491-5p\/C2CD2L axis","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib82","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41388-023-02652-3","article-title":"LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling","volume":"42","author":"Ma","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105446_bib83","first-page":"371","article-title":"Long Non-Coding RNA Expression in Laser Micro-Dissected Luminal A and Triple Negative Breast Cancer Tissue Samples-A Pilot Study","volume":"57","author":"Marcu","year":"2021","journal-title":"Med. (B. Aires)."},{"key":"10.1016\/j.critrevonc.2026.105446_bib84","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature05519","article-title":"Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript","volume":"445","author":"Martianov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105446_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36469","article-title":"LncRNA HIF1A-AS2 promotes triple-negative breast cancer progression and paclitaxel resistance via MRPS23 protein","volume":"10","author":"Min","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.critrevonc.2026.105446_bib86","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14737140.2024.2393251","article-title":"Strategies for the prevention or reversal of PARP inhibitor resistance","volume":"24","author":"Mitri","year":"2024","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib87","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1002\/jcp.30234","article-title":"LncRNA HEIH\/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production","volume":"236","author":"Nafea","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib88","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/cancers16183241","article-title":"Induction of Invasive Basal Phenotype in Triple-Negative Breast Cancers by Long Noncoding RNA BORG","volume":"16","author":"Niazi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acs.bioconjchem.4c00001","article-title":"Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging","volume":"35","author":"Nicolescu","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/cbmi.3c00011","article-title":"Evaluating Dual-Targeted ECO\/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging","volume":"1","author":"Nicolescu","year":"2023","journal-title":"Chem. & Biomed. Imaging"},{"key":"10.1016\/j.critrevonc.2026.105446_bib91","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190468","article-title":"LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC","volume":"39","author":"Niu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib92","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4103\/jcrt.JCRT_282_19","article-title":"MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer","volume":"15","author":"Ou","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib93","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1158\/1541-7786.MCR-21-0137","article-title":"lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing a6 Integrin\/CD49f Expression in Breast Cancer Stem Cells","volume":"19","author":"Parker","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib94","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105446_bib95","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.18632\/oncotarget.7173","article-title":"The hormone response element mimic sequence of GAS5 IncRNA is sufficient to induce apoptosis in breast cancer cells","volume":"7","author":"Pickard","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105446_bib96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1101\/gr.6036807","article-title":"Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs","volume":"17","author":"Ponjavic","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fonc.2019.01459","article-title":"XIST and TSIX Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients","volume":"9","author":"Salama","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib98","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ol.2021.12854","article-title":"Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes","volume":"22","author":"Samir","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105446_bib99","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-022-00555-4","article-title":"Long Non-coding RNA LINC01224 Promotes the Malignant Behaviors of Triple Negative Breast Cancer Cells via Regulating the miR-193a-5p\/NUP210 Axis","author":"Sang","year":"2022","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154579","article-title":"Let-7a\/cMyc\/CCAT1\/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1","volume":"248","author":"Selem","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.critrevonc.2026.105446_bib101","doi-asserted-by":"crossref","DOI":"10.1242\/bio.023135","article-title":"Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression","author":"Sha","year":"2017","journal-title":"Biol. Open. 6 13101316."},{"key":"10.1016\/j.critrevonc.2026.105446_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41420-020-00383-y","article-title":"Single-cell long noncoding RNA transcriptome implicates MALAT1 in triple-negative breast cancer resistance to neoadjuvant chemotherapy","volume":"7","author":"Shaath","year":"2021","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.critrevonc.2026.105446_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1086480","article-title":"Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer","volume":"13","author":"Shang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2020.12.026","article-title":"LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3","volume":"182","author":"Sharma","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.critrevonc.2026.105446_bib105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41417-020-00254-9","article-title":"YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer","volume":"28","author":"Shen","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib106","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2018.12.074","article-title":"YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein","volume":"509","author":"Shen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105446_bib107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13046-021-02015-4","article-title":"LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication","volume":"40","author":"Sheng","year":"2021","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.616098","article-title":"DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer","volume":"10","author":"Sheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib109","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.arcmed.2016.11.001","article-title":"Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer","volume":"47","author":"Shi","year":"2016","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110892","article-title":"FOXCUT regulates the malignant phenotype of triple-negative breast Cancer via the miR-337-3p\/ANP32E Axis","volume":"116","author":"Shi","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.critrevonc.2026.105446_bib111","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2147\/OTT.S237559","article-title":"Knockdown of lncRNA PCAT6 Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating miR-185-5p\/TPD52 Axis","volume":"13","author":"Shi","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib112","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-018-4793-z","article-title":"Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness","volume":"170","author":"Shima","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105446_bib113","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","article-title":"Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness","volume":"10","author":"Shin","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105446_bib114","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.7150\/ijbs.104483","article-title":"MNX1-AS1 suppresses chemosensitivity by activating the PI3K\/AKT pathway in breast cancer","volume":"21","author":"Shuai","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/abbs\/gmz021","article-title":"LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis","volume":"51","author":"Song","year":"2019","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"10.1016\/j.critrevonc.2026.105446_bib116","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105446_bib117","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajpath.2022.11.007","article-title":"DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5\/p27 Signaling","volume":"193","author":"Su","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13000-021-01105-3","article-title":"A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p\/SOX17\/B-catenin axis in triple-negative breast cancer","volume":"16","author":"Sun","year":"2021","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib119","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-23-3854","article-title":"Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer","volume":"84","author":"Sun","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00550","article-title":"SNPs in lncRNA Regions and Breast Cancer Risk","volume":"11","author":"Suvanto","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2026.105446_bib121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/jca.33982","article-title":"Long noncoding rna dcst1-as1 promotes cell proliferation and metastasis in triple-negative breast cancer by forming a positive regulatory loop with miR-873-5p and MYC","volume":"11","author":"Tang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105446_bib122","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181618","article-title":"LncRNA DANCR contributes to tumor progression via targeting miR-216a-5p in breast cancer","volume":"39","author":"Tao","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib123","article-title":"Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer","volume":"14","author":"Tarantino","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105446_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.828160","article-title":"The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31","volume":"12","author":"Tian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023050109","article-title":"Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells","volume":"34","author":"Tracy","year":"2024","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.critrevonc.2026.105446_bib126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1541-7786.MCR-17-0548","article-title":"Mitotically-associated lncRNA (MANCR) affects genomic stability and cell division in aggressive breast cancer","volume":"16","author":"Tracy","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203180119","article-title":"Long noncoding RNA-mediated activation of PROTOR1\/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer","volume":"119","author":"Tu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105446_bib128","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/stem.3055","article-title":"Microenvironmental regulation of long noncoding RNA LINC01133 Promotes cancer stem cell-like phenotypic traits in triple-negative breast cancers","volume":"37","author":"Tu","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.critrevonc.2026.105446_bib129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s42003-022-03539-x","article-title":"MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer","volume":"5","author":"Turco","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/acs.bioconjchem.9b00028","article-title":"Systemic delivery of tumor-targeting siRNA nanoparticles against an oncogenic LncRNA facilitates effective triple-negative breast cancer therapy","volume":"30","author":"Vaidya","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib131","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/cells13221918","article-title":"LUCAT1-Mediated Competing Endogenous RNA ceRNA Network in Triple-Negative Breast Cancer","volume":"13","author":"Verma","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105446_bib132","article-title":"Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer","volume":"10","author":"Vishnubalaji","year":"2023","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.critrevonc.2026.105446_bib133","first-page":"44","article-title":"LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities","volume":"8","author":"Vishnubalaji","year":"2022","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.critrevonc.2026.105446_bib134","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.3390\/cancers17243943","article-title":"Antibody\u2013drug conjugates and beyond: next-generation targeted therapies for breast cancer","volume":"17","author":"Wali","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105446_bib135","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/iub.2910","article-title":"SNHG14 promotes triple-negative breast cancer cell proliferation, invasion, and chemoresistance by regulating the ERK\/MAPK signaling pathway","volume":"76","author":"Wang","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.critrevonc.2026.105446_bib136","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.923507","article-title":"Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating B-Catenin Signaling","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.critrevonc.2026.105446_bib137","doi-asserted-by":"crossref","first-page":"15083","DOI":"10.1002\/jcb.28769","article-title":"LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib138","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbrc.2020.01.170","article-title":"LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p\/TOB1 axis","volume":"526","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105446_bib139","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-018-0869-2","article-title":"LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci","volume":"9","author":"Wang","year":"2018","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105446_bib140","article-title":"Long Non-Coding RNA Neighbor of BRCA1 Gene 2: A Crucial Regulator in Cancer Biology","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102076","article-title":"Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN\/Hippo\/YAP axis","volume":"49","author":"Wang","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib142","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15384101.2018.1442625","article-title":"LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation","volume":"17","author":"Wang","year":"2018","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.critrevonc.2026.105446_bib143","article-title":"LncRNA GHET1 Promotes Hypoxia-Induced Glycolysis, Proliferation, and Invasion in Triple-Negative Breast Cancer Through the Hippo\/YAP Signaling Pathway","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib144","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11010-023-04908-8","article-title":"LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p\/RBM39 axis","volume":"480","author":"Wang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib145","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1002\/jcb.28337","article-title":"HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib146","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.18632\/oncotarget.3441","article-title":"Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105446_bib147","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2016.39","article-title":"Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology","volume":"29","author":"Weisman","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib148","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1096\/fj.202000481R","article-title":"Structure of LINC00511-siRNA-conjugated nanobubbles and improvement of cisplatin sensitivity on triple negative breast cancer","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.critrevonc.2026.105446_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217192","article-title":"Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer","volume":"602","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105446_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108869","article-title":"Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression","volume":"115","author":"Wu","year":"2019","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105446_bib151","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.biopha.2017.11.055","article-title":"Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer","volume":"97","author":"Wu","year":"2018","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105446_bib152","doi-asserted-by":"crossref","first-page":"18191","DOI":"10.18632\/aging.203156","article-title":"Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195\/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib153","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2017.05.136","article-title":"Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy","volume":"489","author":"Xia","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105446_bib154","doi-asserted-by":"crossref","first-page":"424","DOI":"10.18632\/aging.202148","article-title":"LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p","volume":"13","author":"Xing","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib155","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1002\/cam4.5265","article-title":"Glucose metabolism and lncRNAs in breast cancer: Sworn friend","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib156","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1158\/0008-5472.CAN-21-1446","article-title":"LncRNA Uc003xsl.1-Mediated Activation of the NFKB\/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer","volume":"82","author":"Xu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib157","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2020_6227","article-title":"LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299","author":"Xu","year":"2023","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.742360","article-title":"Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Surg."},{"key":"10.1016\/j.critrevonc.2026.105446_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104628","article-title":"Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib160","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.62347\/VIXN9362","article-title":"Construction and validation of immune-associated lncRNA model for predicting immune status and therapeutic reactions of triple-negative breast cancer","volume":"16","author":"Y","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib161","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin Induces Pyroptosis via Activation of MEG3\/NLRP3\/caspase-1\/GSDMD Pathway in Triple-Negative Breast Cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib162","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1038\/s41418-018-0123-6","article-title":"An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer","volume":"25","author":"Yang","year":"2018","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.critrevonc.2026.105446_bib163","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/09168451.2019.1588097","article-title":"LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9","volume":"83","author":"Yang","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib164","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40001-025-02420-x","article-title":"LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p","volume":"30","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib165","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.3390\/cancers14153763","article-title":"A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105446_bib166","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/15384047.2021.1881201","article-title":"YY1-induced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2","volume":"22","author":"Yang","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105446_bib167","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70208","article-title":"Immunosuppressive SOX9-AS1 Resists Triple-Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway","volume":"28","author":"Ye","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105446_bib168","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934522","article-title":"Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer","author":"Yi","year":"2021","journal-title":"Med. Sci. Monit. 27 e934522"},{"key":"10.1016\/j.critrevonc.2026.105446_bib169","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CM9.0000000000002700","article-title":"Promotion effect of FOXCUT as a microRNA sponge for miR-24-3p on progression in triple-negative breast cancer through the p38 MAPK signaling pathway","volume":"137","author":"Yu","year":"2023","journal-title":"Chin. Med. J. (Engl. )."},{"key":"10.1016\/j.critrevonc.2026.105446_bib170","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2149","article-title":"Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.critrevonc.2026.105446_bib171","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12672-025-02538-8","article-title":"PWRN1 low expression facilitates cancer progression and is an unfavorable prognosis factor in breast cancer","volume":"16","author":"Yuan","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib172","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/ol.2023.13917","article-title":"Long non-coding RNA PTCSC3 suppresses triple-negative breast cancer by downregulating long non-coding RNA MIR100HG","volume":"26","author":"Zhang","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105446_bib173","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s13577-022-00685-6","article-title":"Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p\/LZTS2 axis","volume":"35","author":"Zhang","year":"2022","journal-title":"Hum. Cell."},{"key":"10.1016\/j.critrevonc.2026.105446_bib174","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3389\/fphar.2018.01248","article-title":"AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt\/B-Catenin Signaling Pathway in Triple-Negative Breast Cancer","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib175","article-title":"LINC00668 silencing retards tumorigenesis via sponging miR-518c-3p to regulating WDR1 in triple negative breast cancer","volume":"282","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib176","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2147\/CMAR.S288271","article-title":"Imbalance of molecular module of TINCR-miR-761 promotes the metastatic potential of early triple negative breast cancer and partially offsets the anti-tumor activity of luteolin","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2026.105446_bib177","article-title":"Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2026.105446_bib178","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00018-021-04120-1","article-title":"SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K\/Akt signaling","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib179","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1038\/s41598-020-64713-x","article-title":"lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105446_bib180","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nsmb.3211","article-title":"Long noncoding RNA LINP1 regulates double strand DNA break repair in triple negative breast cancer","volume":"23","author":"Zhang","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib181","article-title":"MYC\/TET3-regulated TMEM65 activates OXPHOS-SERPINB3 pathway to promote progression and cisplatin resistance in triple-negative breast cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. )."},{"key":"10.1016\/j.critrevonc.2026.105446_bib182","article-title":"LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105446_bib183","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1440-1681.13758","article-title":"LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p\/PIK3C3 mediated autophagy","volume":"50","author":"Zheng","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib184","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/jcb.29445","article-title":"lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p\/SUFU signaling","volume":"121","author":"Zheng","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105446_bib185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-020-00852-y","article-title":"Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer","volume":"13","author":"Zheng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105446_bib186","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/CAD.0000000000001253","article-title":"LncRNA PCAT6 activated by SP1 facilitates the progression of breast cancer by the miR-326\/LRRC8E axis","volume":"33","author":"Zhu","year":"2022","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105446_bib187","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02355-1","article-title":"Clinical approaches to overcome PARP inhibitor resistance","volume":"24","author":"Zou","year":"2025","journal-title":"Mol. Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:44:58Z","timestamp":1793943898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":187,"alternative-id":["S1040842826003331"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105446","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105446"}}